HCPCS Level II › J

HCPCS Level II codes starting with J

1,255 codes, page 3 of 13. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
J0716 Injection, centruroides immune f(ab)2, up to 120 milligrams Valid
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) Valid
J0720 Injection, chloramphenicol sodium succinate, up to 1 gm Valid
J0725 Injection, chorionic gonadotropin, per 1,000 usp units Valid
J0735 Injection, clonidine hydrochloride, 1 mg Valid
J0736 Injection, clindamycin phosphate, 300 mg Valid
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg Valid
J0738 Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) Valid
J0739 Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) Valid
J0740 Injection, cidofovir, 375 mg Valid
J0741 Injection, cabotegravir and rilpivirine, 2mg/3mg Valid
J0742 Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg Valid
J0743 Injection, cilastatin sodium; imipenem, per 250 mg Valid
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg Valid
J0745 Injection, codeine phosphate, per 30 mg Valid
J0750 Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) Valid
J0751 Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) Valid
J0752 Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) Valid
J0759 Injection, clevidipine butyrate, 1 mg Valid
J0760 Injection, colchicine, per 1 mg through FY2026 Terminated
J0770 Injection, colistimethate sodium, up to 150 mg Valid
J0775 Injection, collagenase, clostridium histolyticum, 0.01 mg Valid
J0780 Injection, prochlorperazine, up to 10 mg Valid
J0791 Injection, crizanlizumab-tmca, 5 mg Valid
J0795 Injection, corticorelin ovine triflutate, 1 microgram through FY2026 Terminated
J0799 Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified Valid
J0800 Injection, corticotropin, up to 40 units through FY2026 Terminated
J0801 Injection, corticotropin (acthar gel), up to 40 units Valid
J0802 Injection, corticotropin (ani), up to 40 units Valid
J0833 Injection, cosyntropin, not otherwise specified, 0.25 mg through FY2026 Terminated
J0834 Injection, cosyntropin, 0.25 mg Valid
J0840 Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram Valid
J0841 Injection, crotalidae immune f(ab')2 (equine), 120 mg Valid
J0850 Injection, cytomegalovirus immune globulin intravenous (human), per vial Valid
J0870 Injection, imetelstat, 1 mg Valid
J0871 Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg Valid
J0872 Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg Valid
J0873 Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg Valid
J0874 Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg Valid
J0875 Injection, dalbavancin, 5 mg Valid
J0877 Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg Valid
J0878 Injection, daptomycin, 1 mg Valid
J0879 Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis) Valid
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) Valid
J0882 Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) Valid
J0883 Injection, argatroban, 1 mg (for non-esrd use) Valid
J0884 Injection, argatroban, 1 mg (for esrd on dialysis) Valid
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units Valid
J0886 Injection, epoetin alfa, 1000 units (for esrd on dialysis) through FY2026 Terminated
J0887 Injection, epoetin beta, 1 microgram, (for esrd on dialysis) Valid
J0888 Injection, epoetin beta, 1 microgram, (for non esrd use) Valid
J0889 Daprodustat, oral, 1 mg, (for esrd on dialysis) through FY2026 Terminated
J0890 Injection, peginesatide, 0.1 mg (for esrd on dialysis) Valid
J0891 Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) Valid
J0892 Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) Valid
J0893 Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg Valid
J0894 Injection, decitabine, 1 mg Valid
J0895 Injection, deferoxamine mesylate, 500 mg Valid
J0896 Injection, luspatercept-aamt, 0.25 mg Valid
J0897 Injection, denosumab, 1 mg Valid
J0898 Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) Valid
J0899 Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) Valid
J0900 Injection, testosterone enanthate and estradiol valerate, up to 1 cc through FY2026 Terminated
J0901 Vadadustat, oral, 1 mg (for esrd on dialysis) Valid
J0911 Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis) Valid
J0945 Injection, brompheniramine maleate, per 10 mg Valid
J1000 Injection, depo-estradiol cypionate, up to 5 mg Valid
J1010 Injection, methylprednisolone acetate, 1 mg Valid
J1020 Injection, methylprednisolone acetate, 20 mg through FY2026 Terminated
J1030 Injection, methylprednisolone acetate, 40 mg through FY2026 Terminated
J1040 Injection, methylprednisolone acetate, 80 mg through FY2026 Terminated
J1050 Injection, medroxyprogesterone acetate, 1 mg Valid
J1060 Injection, testosterone cypionate and estradiol cypionate, up to 1 ml through FY2026 Terminated
J1070 Injection, testosterone cypionate, up to 100 mg through FY2026 Terminated
J1071 Injection, testosterone cypionate, 1 mg Valid
J1072 Injection, testosterone cypionate (azmiro), 1 mg Valid
J1073 Testosterone pellet, implant, 75 mg Valid
J1080 Injection, testosterone cypionate, 1 cc, 200 mg through FY2026 Terminated
J1094 Injection, dexamethasone acetate, 1 mg through FY2026 Terminated
J1095 Injection, dexamethasone 9 percent, intraocular, 1 microgram Valid
J1096 Dexamethasone, lacrimal ophthalmic insert, 0.1 mg Valid
J1097 Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml Valid
J1098 Articaine ophthalmic, 8% solution, 0.4 ml Valid
J1100 Injection, dexamethasone sodium phosphate, 1 mg Valid
J1105 Dexmedetomidine, oral, 1 mcg Valid
J1110 Injection, dihydroergotamine mesylate, per 1 mg Valid
J1120 Injection, acetazolamide sodium, up to 500 mg Valid
J1130 Injection, diclofenac sodium, 0.5 mg Valid
J1160 Injection, digoxin, up to 0.5 mg Valid
J1162 Injection, digoxin immune fab (ovine), per vial Valid
J1163 Injection, diltiazem hydrochloride, 0.5 mg Valid
J1164 Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg Valid
J1165 Injection, phenytoin sodium, per 50 mg Valid
J1170 Injection, hydromorphone, up to 4 mg through FY2026 Terminated
J1171 Injection, hydromorphone, 0.1 mg Valid
J1180 Injection, dyphylline, up to 500 mg Valid
J1190 Injection, dexrazoxane hydrochloride, per 250 mg Valid
J1200 Injection, diphenhydramine hcl, up to 50 mg Valid
J1201 Injection, cetirizine hydrochloride, 0.5 mg Valid
J1202 Miglustat, oral, 65 mg Valid
Page 3 of 13